American Society of Hematology
(UPDATE) Ixazomib
Elotuzumab
Update Carfilzomib Kyprolis
CancerCare
NCCN Guidelines for Patients: Multiple Myeloma
The Leukemia and Lymphoma Society
International Myeloma Foundation (IMF)